Novo Nordisk commits to gender equality
This article was originally published in Scrip
Novo Nordiskis helping to achieve the United Nations' Millennium Development Goal number 3: to empower women and promote gender equality. The company says that it will help women with diabetes in the developing world through improving the prevention, diagnosis and treatment of the condition. "Women have a higher diabetes-related morbidity and mortality due to biological, cultural and socioeconomic factors … women are often at a disadvantage getting diagnosed and receiving proper treatment," said Lise Kingo, the company's executive vice-president. Novo Nordisk will also co-host a forum on Women, Diabetes and Development in New York alongside the World Diabetes Foundation and the Global Alliance for Women's Health on September 24th.
You may also be interested in...
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
Patient access schemes have helped the Scottish Medicines Consortium recommend rare disease products, including Regeneron/Sanofi’s Libtayo for skin cancer.